Trial Profile

A Phase 2, Multicenter, Randomized, Double-Blind, Multiple-Dose, Placebo Controlled Clinical Trial of Two Doses of PP-01 for the Mitigation of Cannabis Withdrawal Symptoms

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 18 Jun 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

15 Jun 2026 According to a PleoPharma, Inc. media release, data from the trial will be presented at the College on Problems of Drug Dependence (CPDD) 88th Annual Scientific Meeting, taking place June 13-17, 2026, in Portland, Oregon.
19 Jun 2025 Results presented in the PleoPharma Media Release.
19 Jun 2025 According to a PleoPharma, Inc. media release, the company presented a poster presentation on June 17, 2025 and an oral presentation on June 18, 2025 from this trial at the 2025 annual meeting of The College on Problems of Drug Dependence in New Orleans, LA.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com